Supernus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	128.45	69.33	75.05	93.12	203.43
Short-Term Investments	180.22	384.28	179.82	368.21	136.25
Cash & Short-Term Investments	308.67	453.61	254.87	461.33	339.68
Cash Growth	-31.95%	77.98%	-44.75%	35.81%	-19.61%
Receivables	187.8	142.08	144.16	165.5	148.93
Inventory	82.39	54.29	77.41	91.54	85.96
Prepaid Expenses	65.33	36.09	16.68	15.78	27.02
Total Current Assets	644.18	686.07	493.11	734.15	601.59
Property, Plant & Equipment	10.53	36.02	42.52	44.08	52.32
Long-Term Investments	-	-	16.62	93.9	119.17
Goodwill	124.88	117.02	117.02	117.02	117.52
Other Intangible Assets	569.46	521.91	599.89	702.46	784.69
Long-Term Deferred Tax Assets	38.35	-	-	-	-
Other Long-Term Assets	65.25	7.05	8.51	10.9	13.87
Total Assets	1,453	1,368	1,278	1,703	1,689
Accounts Payable	107.8	4.59	1.96	10.54	9.33
Accrued Expenses	-	180.21	166.26	185.67	199.47
Current Portion of Long-Term Debt	-	-	-	407.97	7.24
Current Portion of Leases	-	6.89	8.33	6.79	6.48
Other Current Liabilities	230.37	100.72	113.64	76.99	92.86
Total Current Liabilities	338.17	292.4	290.2	687.96	315.38
Long-Term Debt	-	-	-	-	385.23
Long-Term Leases	30.37	27.38	33.2	36	41.3
Long-Term Deferred Tax Liabilities	-	4.96	24.96	49.81	85.36
Other Long-Term Liabilities	22.4	7.6	7.8	42.54	46.04
Total Liabilities	390.93	332.34	356.16	816.3	873.3
Common Stock	0.06	0.06	0.06	0.05	0.05
Additional Paid-In Capital	543.83	479.44	439.49	408.12	434.34
Retained Earnings	517.88	556.43	482.56	481.25	379.92
Comprehensive Income & Other	-0.04	-0.19	-0.59	-3.21	1.54
Shareholders' Equity	1,062	1,036	921.52	886.2	815.85
Total Liabilities & Equity	1,453	1,368	1,278	1,703	1,689
Total Debt	30.37	34.27	41.53	450.76	440.25
Net Cash (Debt)	278.31	419.34	229.96	104.47	18.6
Net Cash Growth	-33.63%	82.35%	120.12%	461.74%	-94.47%
Net Cash Per Share	4.93	7.49	4.14	1.69	0.34
Filing Date Shares Outstanding	57.46	55.81	54.73	54.38	53.39
Total Common Shares Outstanding	57.46	55.74	54.72	54.25	53.26
Working Capital	306.01	393.67	202.92	46.19	286.21
Book Value Per Share	18.48	18.58	16.84	16.33	15.32
Tangible Book Value	367.38	396.8	204.61	66.72	-86.36
Tangible Book Value Per Share	6.39	7.12	3.74	1.23	-1.62
Machinery	-	14.48	14.03	13.11	14.23
Construction In Progress	-	-	-	0.21	0.03
Leasehold Improvements	-	14.02	14.02	14.02	14.37

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q